Accretion Pharmaceuticals Limited
Accretion Pharmaceuticals Limited, established in 2012, produces and sells tablets, capsules, and healthcare products, offering both generic and branded formulations. It provides contract manufacturing services for domestic and international clients, including government and private institutions.
What Accretion files
- Others33
- Investor Meet12
- Updates8
- Important3
- Board Meeting2
- PPTs2
Accretion Pharma showed strong FY26 performance. Revenue jumped 56.21% YoY to ₹89.6 crore, with Profit After Tax up 42.30% YoY to ₹9.7 crore. Growth was fueled by higher volumes and an improved product mix, especially in Oral Liquids and Tablets. EBITDA for the year stood at ₹15.0 crore with a...
Accretion Pharma reported robust half-year results (H1 FY26) with revenue jumping 135.59% YoY to ₹43.74 Cr. Profit after tax (PAT) surged 92.81% YoY to ₹4.75 Cr, while EBITDA grew 62.94% to ₹7.07 Cr. This strong performance is driven by its integrated CDMO and private-label formulation model, covering oral solids, liquids,...